Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Clinical trial NCT00324324 · TERMINATED

Trial details

NCT number: NCT00324324
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Breast Cancer Chronic Myeloproliferative Disorders Gestational Trophoblastic Tumor Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Neuroblastoma Ovarian Cancer Testicular Germ Cell Tumor

Start date: 2006-05-01
Primary completion: 2007-04-01
Enrollment: 240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.